Highly Active Antiretroviral Therapy Started during Pregnancy or Postpartum Suppresses HIV‐1 RNA, but Not DNA, in Breast Milk
Author(s) -
Roger Shapiro,
Thumbi Ndung’u,
Shahin Lockman,
Laura Smeaton,
Ibou Thior,
C. William Wester,
Lisa Stevens,
Gaseene Sebetso,
Simani Gaseitsiwe,
Trevor Peter,
Max Essex
Publication year - 2005
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/432489
Subject(s) - pregnancy , breast milk , antiretroviral therapy , medicine , virology , rna , human immunodeficiency virus (hiv) , dna , obstetrics , lentivirus , viral load , biology , viral disease , genetics , biochemistry , gene
The ability of highly active antiretroviral therapy (HAART) to reduce human immunodeficiency virus type 1 (HIV-1) RNA and DNA in breast milk has not been described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom